Communication about vaccine efficacy and COVID-19 vaccine choice: Evidence from a survey experiment in the United States백신 효능 및 COVID-19 백신 선택에 대한 커뮤니케이션: 미국에서 실시한 설문조사 실험의 증거Article Published on 2022-03-302022-09-11 Journal: PLoS ONE [Category] 변종, [키워드] Affect American asked black choice clinical trial combined efficacy communication control group COVID-19 COVID-19 vaccine criteria death defined Efficacy experiment Health Hospitalization information inoculated Latino mass vaccination Metrics mRNA mRNA vaccine offer outcome pair Pfizer/BioNTech preference reported Result significantly more Strong symptomatic symptomatic infection the United State Treatment treatment groups vaccination Vaccine vaccine efficacy Vaccine hesitancy Vaccines variants Viral vector vaccine while [DOI] 10.1371/journal.pone.0265011 PMC 바로가기 [Article Type] Article
Pegcetacoplan for paroxysmal nocturnal hemoglobinuriaResearch article Published on 2022-03-292022-10-05 Journal: Blood [Category] 비임상, [키워드] Anemia approach clinical study complement Complement inhibitor derivatives effective Hemolysis inhibit inhibitor paroxysmal nocturnal hemoglobinuria Patient resulting Sequencing symptomatic Treatment [DOI] 10.1182/blood.2021014868 [Article Type] Research article
Tracking the temporal variation of COVID-19 surges through wastewater-based epidemiology during the peak of the pandemic: A six-month long study in Charlotte, North Carolina전염병이 정점에 달했을 때 폐수 기반 역학을 통해 COVID-19 급증의 시간적 변화 추적: 노스캐롤라이나주 샬럿에서 6개월 동안의 연구Article Published on 2022-03-252022-09-11 Journal: The Science of the total environment [Category] SARS, 치료기술, 치료법, 치료제, [키워드] analyzed anomalies approach Asymptomatic average causative agent clinically Community Concentration coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 case COVID-19 infection Epidemiology fecal function global pandemic infected individuals influent information molecular analyses MONITOR monitoring N1 and N2 North nucleocapsid occur performed plant plants positive correlation positively correlated Prevalence qPCR quantification ranged reported RT-ddPCR RT-qPCR SARS-CoV-2 SARS-CoV-2 RNA service Spread symptomatic Treatment Variation virus wastewater wastewater-based epidemiology (WBE) WHO [DOI] 10.1016/j.scitotenv.2021.152503 PMC 바로가기 [Article Type] Article
Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers의료 및 대학 근로자의 SARS-CoV-2 항체 유병률에 대한 장기 종단 평가Article Published on 2022-03-252022-09-11 Journal: Scientific Reports [Category] SARS, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyzed Asymptomatic contribute coronavirus Evolution Follow-up healthcare hospital IgA antibodies IgG IgG level IgG levels IgM IgM and IgG infections natural infection participant Participants pauci-symptomatic persistence positive Prevalence SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 IgG serology seropositive participant severe acute respiratory syndrome Coronavirus sustained symptomatic tested [DOI] 10.1038/s41598-022-09215-8 PMC 바로가기 [Article Type] Article
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study Research Published on 2022-03-222022-10-05 Journal: Scientific Reports [Category] SARS, 치료법, 치료제, [키워드] Analysis Anosmia Campania Case fatality rate collected common Comorbidities comparable cough COVID-19 death diagnosis of COVID-19 died enrolled evaluate fatigue Fever Follow-up General population Hospitalization Immunosuppression incidence intensive care unit Italian liver liver transplant male median age Mortality multivariable logistic regression outcome outpatients Patient patients patients with COVID-19 recipient required respiratory risk factor Symptom symptomatic Univariate analysis [DOI] 10.1038/s41598-022-08947-x [Article Type] Research
Definition of the Immune Parameters Related to COVID-19 SeverityCOVID-19 심각도와 관련된 면역 매개변수의 정의Article Published on 2022-03-182022-09-11 Journal: Frontiers in Immunology [Category] SARS, 치료기술, [키워드] 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Administered Admission allocation among others Analysis analyzed Blood blood cell blood cell count caused Cell changes in clinical decision Clinical management Cohort coronavirus COVID-19 COVID-19 outcome COVID-19 patients Critical Cutoff defined Definition described disease disease severity fluctuations for inclusion granulocyte groups highlight Hospitalization hospitalized COVID-19 patient hospitalized COVID-19 patients immunological immunological changes intensive care intensive care unit admission Laboratory Laboratory test lymphocyte Medical resources Mild moderate non-survivor offer outcome oxygen oxygen support Oxygen therapy parameter Patient Peripheral blood peripheral blood cell peripheral blood cells predict Predictive proof recorded ROC Curve sensitivity separated severe acute respiratory syndrome Coronavirus severity Severity of disease Severity Score specificity survival survivor symptomatic the disease therapy Triage [DOI] 10.3389/fimmu.2022.850846 PMC 바로가기 [Article Type] Article
Impact of prior vaccination with Covishield TM and Covaxin® on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in South India during April and May 2021: a cohort study2021년 4월과 5월에 남인도에서 2차 대유행 기간 동안 Covishield TM 및 Covaxin®을 사용한 사전 예방 접종이 증상이 있는 COVID-19 환자의 사망률에 미치는 영향: 코호트 연구Article Published on 2022-03-182022-09-11 Journal: Vaccine [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval Adjusted analysis Admission age Astra Zeneca circulation Cohort cohort study Corona Corona virus COVAXIN® COVID-19 COVID-19 patient COVID-19 patients COVID-19 vaccine COVID-19 vaccines COVISHIELDTM dose doses Emergency use evaluated expressed greater Hospitalization ICU ICU admission Impact impacted indeterminate India intensive care intensive care unit mitigate Mortality NIV non-invasive ventilation Oxford oxygen Oxygen therapy pandemic Patient patients presenting Primary outcome reduced risk risk ratio RT-PCR second wave severity severity of illness south India symptomatic vaccination Vaccine variant were assessed widespread [DOI] 10.1016/j.vaccine.2022.02.023 PMC 바로가기 [Article Type] Article
Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination settingClinical Trial Published on 2022-03-102022-10-05 Journal: Blood [Category] SARS, 임상, [키워드] 1:1 95% CI Active disease Analysis controls COVID-19 COVID-19 immunity COVID-19 infection COVID-19 vaccine COVID-19-related death doses Effectiveness ENhance evaluated hematological Hospitalization humoral immune system Immunity increased risk Infection mRNA BNT162b2 vaccine neoplasm Neoplasms observation outcome Patient patient population patients patients receiving treatment polymerase chain receiving recipient risk severe COVID-19 symptomatic therapy Treatment vaccinated individual vaccination vaccine dose [DOI] 10.1182/blood.2021013768 PMC 바로가기 [Article Type] Clinical Trial
Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States—January–July, 2021Research Article Published on 2022-03-092022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] accumulate Affect average COVID-19 COVID-19 case COVID-19 vaccine disease drug Efficacy expected FDA food help occur occurred Occurrence per day public health messaging reported SARS-CoV-2 transmission symptomatic symptomatic SARS-CoV-2 infection the United State The United States Trial understanding vaccinated individual Vaccine vaccine breakthrough infection vaccine breakthrough infections Vaccines [DOI] 10.1371/journal.pone.0264179 PMC 바로가기 [Article Type] Research Article
Persistent SARS-CoV-2 infection in asymptomatic young adultsLetter Published on 2022-03-092022-10-29 Journal: Signal Transduction and Targeted Therapy [Category] COVID-19, MERS, SARS, [키워드] activated Analysis antibody Asymptomatic Asymptomatic case CD4 CD8 comparable contribute contributing to correlated dysregulation Evolution of SARS-CoV-2 immune response immune responses Immunocompromised Infection Infectious diseases investigated mechanism memory B Mutation persistent positive regulatory T cells reported SARS-COV-2 infection SARS-CoV-2 RNA significantly lower specific antibody symptomatic symptomatic cases T cell T cells three group upregulation virus Whole-genome sequence [DOI] 10.1038/s41392-022-00931-1 PMC 바로가기 [Article Type] Letter